Actinobac Biomed, a company founded by Rutgers School of Dental Medicine researcher Scott Kachlany, PhD, has received U.S. Food and Drug Administration approval to begin a Phase I clinical trial.

The global pandemic has led to more than 600,000 deaths in the United States, but COVID-19’s reach is even greater, as a significant increase in mortality rates for heart disease and diabetes has been revealed. In 2020, death rates for…

Orthobrain, an Ohio-based startup, is focused on educating dentists on practical, profitable orthodontic procedures.

While hundreds of Americans still die each day due to COVID-19, the overall death rate has dropped 90% since its height in January 2021. However, people who are unvaccinated remain the most vulnerable to severe morbidity and mortality due…

Periodontal disease and poor oral hygiene may be a more accurate predictor for COVID-19 severity than other risk factors, a study has found.

With children ages 12 to 17 now eligible for COVID-19 vaccination, many families have jumped at the chance to protect their older kids from SARS-CoV-2 infection. However, what about children younger than 12? Pfizer is now starting another…

The Pennsylvania Early Learning Investment Commission has recognized Benco Dental as one of four businesses whose private investments encourage quality care and early learning, as well as innovative and excellent supports for working…

A new study published in JAMA Internal Medicine found that Facebook groups responsible for spreading misinformation about the global pandemic had high levels of automated software link sharing, an indicator that bots are behind the data…

Benco Dental has finalized a definitive agreement to purchase the assets of ADI Mobile Health.

On today's episode of The Art of Dental Finance and Management podcast, Art meets with Jim Donovan, Partner-in-Charge of the Employee Retention Credit (ERC) program at Eide Bailly. Art and Jim discuss the lessons they’ve learned throughout…